Two studies recently released show a survival benefit for intraperitoneal IP chemotherapy
Related Topics

Ovarian Cancer Research Alliance Names Winners of Two Prizes in Recognition of Notable Research
Ovarian Cancer Research Alliance (OCRA), the largest global organization dedicated to advancing ovarian and related gynecologic cancer research, announced today the recipients of two prizes awarded for noteworthy work in … Continued

The Overview: January 2025
OCRA Joins Forces With Rivkin Center for Ovarian Cancer Research Ovarian Cancer Research Alliance (OCRA) has announced that the Rivkin Center for Ovarian Cancer Research will join with OCRA effective … Continued

How OCRA-Funded Research is Harnessing AI and Nanotechnology for Earlier Ovarian Cancer Detection, a Conversation with Clarke’s Closer Look
In a new interview with journalist Marcel Clarke for Clarke’s Closer Look, OCRA grantee Dr. Daniel Heller of Memorial Sloan Kettering Cancer Center discusses how his lab is utilizing artificial … Continued